首页> 外文期刊>BMC Anesthesiology >Multicenter assessment of sedation and delirium practices in the intensive care units in Poland - is this common practice in Eastern Europe?
【24h】

Multicenter assessment of sedation and delirium practices in the intensive care units in Poland - is this common practice in Eastern Europe?

机译:波兰重症监护病房的镇静和ir妄习惯多中心评估-东欧是否普遍使用这种做法?

获取原文
           

摘要

Background The majority of critically ill patients experience distress during their stay in the Intensive Care Unit (ICU), resulting from systemic illness, multiple interventions and environmental factors. Providing humane care should address concomitant treatment of pain, agitation and delirium. The use of sedation and approaches to ICU delirium should be monitored according to structured guidelines. However, it is unknown to what extent these concepts are followed in Eastern European countries like Poland. The aim of this study was to evaluate sedation and delirium practices in ICUs in Poland, as a representative of the Eastern European block, particularly the implementation of sedation and ICU delirium screening tools, availability of written sedation guidelines, choice of sedation and delirium treatment agents. Methods A national postal survey was conducted in all Polish ICUs in early 2016. Results A total of 165 responses out of 436 addressed units were received (37.8%). Out of responding ICUs delirium is monitored in only 11.9% of the units in Poland. Sedation monitoring tool is used in only 46.1% of units. Only 19.4% of ICUs have written protocols for sedation and 32.1% do not practice daily sedation interruption. The most frequently used agents for short-term sedation ( 24?h). The preferred agents for delirium treatment were haloperidol (77.6%), dexmedetomidine (43.6%) and quetiapine (19.4%). Close to one-third (32.7%) of respondents chose a benzodiazepine (diazepam) for ICU delirium treatment. Non-pharmacological treatment for ICU delirium was reported by only 45% of the respondents. Conclusions A majority of Polish ICUs do not adhere to international guidelines regarding sedation and delirium practices. There continues to be inadequate use of sedation and delirium monitoring tools. High usage of benzodiazepines for sedation and ICU delirium treatment reveals persistence of non-evidence-based practice. This study should prompt further assessment of other Eastern Europe countries and help generate a collective response to update these aspects of patient safety and comfort.
机译:背景大多数重症患者在重症监护病房(ICU)期间会因系统疾病,多种干预措施和环境因素而感到痛苦。提供人文关怀应解决疼痛,躁动和ir妄的伴随治疗。镇静剂和ICUir妄的使用方法应根据结构化指南进行监测。但是,在波兰等东欧国家中遵循这些概念的程度尚不清楚。这项研究的目的是评估作为东欧地区代表的波兰ICU的镇静和del妄实践,尤其是镇静和ICU ir妄筛查工具的实施,书面镇静指南的可用性,镇静剂和del妄治疗剂的选择。方法2016年初,对波兰所有ICU进行了一次全国邮政调查。结果在436个寻址单元中,共收到165份答复(占37.8%)。在未响应的ICU中,仅在波兰11.9%的单位中监测到del妄。镇静监测工具仅用于46.1%的单位。只有19.4%的ICU制定了镇静书面协议,而32.1%的患者未进行每日镇静措施。最常用的短期镇静剂(24小时)。 del妄治疗的首选药物是氟哌啶醇(77.6%),右美托咪定(43.6%)和喹硫平(19.4%)。接近三分之一(32.7%)的受访者选择苯二氮卓(地西ze)进行ICU ir妄治疗。仅45%的受访者报告了ICU ir妄的非药物治疗。结论波兰的大多数ICU不遵守有关镇静和del妄习惯的国际准则。镇静和del妄监测工具的使用仍然不足。苯二氮卓类药物在镇静和ICU ir妄治疗中的大量使用表明了非循证医学实践的持续存在。这项研究应促使对其他东欧国家进行进一步评估,并有助于产生集体反应,以更新患者安全性和舒适性的这些方面。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号